{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:33:08Z","timestamp":1788816788957,"version":"build-2803163510"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117032","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:45:12Z","timestamp":1781455512000},"page":"117032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From fermentation to pharmabiotics: engineering kefir-derived Lactobacillus for targeted intratumoral immunotherapy in colorectal Cancer"],"prefix":"10.1016","volume":"185","author":[{"given":"Trideep","family":"Saikia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Rajak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Moni","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.intimp.2026.117032_bb0005","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.3390\/cancers13246206","article-title":"The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis","volume":"13","author":"Chandra","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ol.2011.432","article-title":"Mechanisms regulating colorectal cancer cell metastasis into liver (review)","volume":"3","author":"Jin","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2026.117032_bb0015","article-title":"Colorectal cancer tumor microenvironment","author":"Karalis","year":"2022","journal-title":"Encyclopedia.pub."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/biomedicines9091075","article-title":"Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects","volume":"9","author":"Makaremi","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.117032_bb0025","doi-asserted-by":"crossref","first-page":"1016646","DOI":"10.3389\/fimmu.2022.1016646","article-title":"Mechanism and strategies of immunotherapy resistance in colorectal cancer","volume":"13","author":"Shan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41416-024-02892-4","article-title":"VEGF-C propagates \u2018onward\u2019 colorectal cancer metastasis from liver to lung","volume":"132","author":"Poghosyan","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117032_bb0035","doi-asserted-by":"crossref","first-page":"1403533","DOI":"10.3389\/fimmu.2024.1403533","article-title":"Immune checkpoint inhibitors in colorectal cancer: limitation and challenges","volume":"15","author":"Yan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117032_bb0040","doi-asserted-by":"crossref","first-page":"1161048","DOI":"10.3389\/fonc.2023.1161048","article-title":"The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives","volume":"13","author":"Gandini","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117032_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104775","article-title":"Immunotherapy in microsatellite-stable colorectal cancer: strategies to overcome resistance","volume":"212","author":"Chen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0050","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/biomedicines12040740","article-title":"Intestinal dysbiosis: microbial imbalance impacts on colorectal cancer initiation, progression and disease mitigation","volume":"12","author":"Garvey","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117032_bb0060","article-title":"Engineering the gut to fight cancer. Cancer Research From Technology","author":"Ely","year":"2025","journal-title":"Networks"},{"issue":"11","key":"10.1016\/j.intimp.2026.117032_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12032-017-1044-9","article-title":"Kefir: a powerful probiotics with anticancer properties","volume":"34","author":"Sharifi","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.intimp.2026.117032_bb0070","doi-asserted-by":"crossref","first-page":"1442888","DOI":"10.3389\/fphar.2024.1442888","article-title":"Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications","volume":"15","author":"Avci","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0075","article-title":"Tumor microenvironment: a complex landscape of cancer development and drug resistance","volume":"17","author":"Fatima","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2026.117032_bb0080","article-title":"Tumor microenvironment shapes colorectal cancer progression, metastasis, and treatment responses","volume":"9","author":"Li","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","article-title":"Heterogeneity of the tumor immune microenvironment and its clinical relevance","volume":"11","author":"Jia","year":"2022","journal-title":"Exp Hematol Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0090","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1002\/cam4.5698","article-title":"Role of tumor microenvironment in cancer progression and therapeutic strategy","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.24384","article-title":"Hepatic stellate cells: partners in crime for liver metastases?","volume":"54","author":"Kang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117032_bb0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fimmu.2018.00070","article-title":"Tissue-dependent tumor microenvironments and their impact on immunotherapy responses","volume":"9","author":"Oliver","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117032_bb0105","article-title":"Colorectal cancer-infiltrating regulatory T cells: functional heterogeneity, metabolic adaptation, and therapeutic targeting","volume":"13","author":"Revilla","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","article-title":"Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer","volume":"60","author":"Ladoire","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0115","doi-asserted-by":"crossref","first-page":"15373","DOI":"10.1038\/ncomms15373","article-title":"Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells","volume":"8","author":"Vazquez-Lombardi","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0120","first-page":"1153","article-title":"CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat","volume":"1","author":"Solomon","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2026.117032_bb0125","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","article-title":"MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy","volume":"32","author":"Ibrahim","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0135","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20061104","article-title":"Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function","volume":"203","author":"Serafini","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117032_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117032_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819849068","article-title":"Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR\/PI3K\/AKT\/MTOR pathway","volume":"18","author":"Lian","year":"2019","journal-title":"Technol Cancer Res Treat."},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0150","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/jf1049968","article-title":"Oral administration of kefiran induces changes in the balance of immune cells in a murine model","volume":"59","author":"Medrano","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.117032_bb0155","doi-asserted-by":"crossref","first-page":"1113378","DOI":"10.3389\/fphar.2023.1113378","article-title":"CAFs orchestrates tumor immune microenvironment\u2014a new target in cancer therapy?","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117032_bb0160","doi-asserted-by":"crossref","first-page":"1617662","DOI":"10.3389\/fimmu.2025.1617662","article-title":"Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5114\/wo.2016.65605","article-title":"Increased transforming growth factor \u03b2 and interleukin 10 transcripts in peripheral blood mononuclear cells of colorectal cancer patients","volume":"6","author":"Stanilov","year":"2016","journal-title":"Wspolczesna Onkol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0175","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2026.117032_bb0180","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/biom14111458","article-title":"Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models","volume":"14","author":"Avsharian","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.117032_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.792691","article-title":"The role of the tumor microenvironment and treatment strategies in colorectal cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"42","key":"10.1016\/j.intimp.2026.117032_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507820","article-title":"Engineering bacteria as living therapeutics in cancer therapy","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70994","article-title":"Gut microbiota reshapes the tumor microenvironment and affects the efficacy of colorectal cancer immunotherapy","volume":"14","author":"Wang","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13099-025-00734-z","article-title":"Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies","volume":"17","author":"Song","year":"2025","journal-title":"Gut Pathog."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0205","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/microorganisms13061410","article-title":"The interplay between the gut microbiota and colorectal cancer: a review of the literature","volume":"13","author":"Cintoni","year":"2025","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/microorganisms12061111","article-title":"Contribution of pks+ Escherichia coli to colon carcinogenesis","volume":"12","author":"Sadeghi","year":"2024","journal-title":"Microorganisms"},{"issue":"16","key":"10.1016\/j.intimp.2026.117032_bb0215","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.3390\/cancers13164054","article-title":"Microbiota-associated metabolites and related immunoregulation in colorectal cancer","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117032_bb0220","doi-asserted-by":"crossref","first-page":"1575452","DOI":"10.3389\/fimmu.2025.1575452","article-title":"Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments","volume":"16","author":"Eiman","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0230","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20250378","article-title":"Microbiota-centered interventions to boost immune checkpoint blockade therapies","volume":"222","author":"Almonte","year":"2025","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.intimp.2026.117032_bb0235","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.3390\/cancers17193247","article-title":"Fusobacterium nucleatum and its impact on colorectal cancer chemoresistance: a meta-analysis of in vitro co-culture infections","volume":"17","author":"Risoen","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0240","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers17030368","article-title":"Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights","volume":"17","author":"Galasso","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117032_bb0245","doi-asserted-by":"crossref","first-page":"1795703","DOI":"10.3389\/fimmu.2026.1795703","article-title":"Microbe-driven immune suppression in colorectal cancer: the Fusobacterium nucleatum playbook","volume":"17","author":"Wuyi","year":"2026","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/cancers17050723","article-title":"Bacterial-mediated in situ engineering of tumour-associated macrophages for cancer immunotherapy","volume":"17","author":"Kuhl","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","article-title":"Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc","volume":"20","author":"Abed","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13099-025-00775-4","article-title":"Fusobacterium nucleatum: a transboundary pathogen in host-microbiota networks","volume":"17","author":"Gao","year":"2025","journal-title":"Gut Pathog"},{"key":"10.1016\/j.intimp.2026.117032_bb0265","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/IDR.S232982","article-title":"The battle of probiotics and their derivatives against biofilms","volume":"13","author":"Barzegari","year":"2020","journal-title":"Infect Drug Resist."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0270","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/microorganisms8091318","article-title":"Bacterial populations in international artisanal kefirs","volume":"8","author":"Sindi","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1574-6968.2011.02290.x","article-title":"High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain","volume":"320","author":"Dobson","year":"2011","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13027-025-00676-w","article-title":"Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions","volume":"20","author":"Kowsarkhizi","year":"2025","journal-title":"Infect Agents Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0285","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/nu18050796","article-title":"Probiotic-driven competitive exclusion in the human gut: a meta-analysis of microbial diversity and pathogen suppression","volume":"18","author":"Alshatari","year":"2026","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"issue":"6264","key":"10.1016\/j.intimp.2026.117032_bb0295","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0300","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.idairyj.2006.02.012","article-title":"Characterization of bacteriocin ST8KF produced by a kefir isolate Lactobacillus plantarum ST8KF","volume":"17","author":"Powell","year":"2007","journal-title":"Int. Dairy J."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AEM.64.2.439-445.1998","article-title":"Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential","volume":"64","author":"McAuliffe","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01382-25","article-title":"Structural and functional insights into lactobacin A: a novel non-pediocin-like bacteriocin from a LiquoriLactobacillus strain related to L. mali","volume":"14","author":"Komori","year":"2026","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.intimp.2026.117032_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.foodcont.2015.03.013","article-title":"Biopreservative effect of the natural antimicrobial substance from Lactobacillus paracasei subsp. tolerans FX-6 on fresh pork during chilled storage","volume":"56","author":"Miao","year":"2015","journal-title":"Food Control"},{"key":"10.1016\/j.intimp.2026.117032_bb0320","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3389\/fmicb.2015.01177","article-title":"Milk kefir: composition, microbial cultures, biological activities, and related products","volume":"6","author":"Prado","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117032_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100925","article-title":"Characterisation of kefir-derived lactic acid bacteria and their extracellular vesicles","volume":"9","author":"Li","year":"2024","journal-title":"Curr Res Food Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0330","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S1517-83822013000200001","article-title":"Microbiological, technological and therapeutic properties of kefir: a natural probiotic beverage","volume":"44","author":"De Oliveira Leite","year":"2013","journal-title":"Braz. J. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0335","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3892\/ijo.2014.2635","article-title":"Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion","volume":"45","author":"Khoury","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0340","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/foods10061210","article-title":"Kefir and its biological activities","volume":"10","author":"Azizi","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.intimp.2026.117032_bb0345","doi-asserted-by":"crossref","first-page":"9081738","DOI":"10.1155\/2021\/9081738","article-title":"Bioactive compounds from kefir and their potential benefits on health: a systematic review and meta-analysis","volume":"2021","author":"Vieira","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"19","key":"10.1016\/j.intimp.2026.117032_bb0350","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1039\/D2FO01747D","article-title":"Lactobacillus kefiranofaciens ZW18 from kefir enhances the anti-tumor effect of anti-programmed cell death 1 immunotherapy by modulating the gut microbiota","volume":"13","author":"Zhao","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2026.117032_bb0355","article-title":"Gut microbiota: a promising milestone in enhancing the efficacy of PD1\/PD-L1 blockade therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117032_bb0360","doi-asserted-by":"crossref","first-page":"1335975","DOI":"10.3389\/fimmu.2024.1335975","article-title":"Probiotic lactic acid bacteria promote anti-tumor immunity through enhanced MHC class I-restricted antigen presentation machinery in dendritic cells","volume":"15","author":"Saito","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0365","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers12020368","article-title":"Immune responses raised in an experimental colon carcinoma model following oral administration of Lactobacillus casei","volume":"12","author":"Aindelis","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0370","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/01635580903407197","article-title":"Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis","volume":"62","author":"Baldwin","year":"2010","journal-title":"Nutr. Cancer"},{"issue":"15","key":"10.1016\/j.intimp.2026.117032_bb0375","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.7150\/jca.94530","article-title":"Preliminary study on the active substances and cellular pathways of lactic acid bacteria for colorectal cancer treatment","volume":"15","author":"Zhao","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2026.117032_bb0380","first-page":"26(S1)","article-title":"Kefir inhibits proliferation and induces apoptosis of epithelial colorectal adenocarcinoma cells","author":"Rizk","year":"2012","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0385","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/toxins11010017","article-title":"Lactobacillus bulgaricus or Lactobacillus rhamnosus suppresses NF-\u03baB signaling pathway and protects against AFB1-induced hepatitis","volume":"11","author":"Chen","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2026.117032_bb0390","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2016.07.001","article-title":"Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model","volume":"83","author":"Gamallat","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.117032_bb0395","doi-asserted-by":"crossref","first-page":"1140463","DOI":"10.3389\/fimmu.2023.1140463","article-title":"Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0400","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3390\/cancers14071853","article-title":"Anticancer potential of post-fermentation media and cell extracts of probiotic strains: an in vitro study","volume":"14","author":"Nowak","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0405","doi-asserted-by":"crossref","first-page":"2046246","DOI":"10.1080\/19490976.2022.2046246","article-title":"Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice","volume":"14","author":"Zhang","year":"2022","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0410","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00189-23","article-title":"The efficacy of prevention for colon cancer based on microbiota therapy and antitumor mechanisms with dietary Lactobacillus intervention","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiol. Spectrum"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0415","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/vaccines8020329","article-title":"Modulation of anti-tumour immune responses by probiotic bacteria","volume":"8","author":"Aindelis","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0420","doi-asserted-by":"crossref","first-page":"2341717","DOI":"10.1080\/19490976.2024.2341717","article-title":"Probiotics enhance effectiveness of tumor immunotherapy via mediating gut microbiome","volume":"16","author":"Jiang","year":"2024","journal-title":"Gut Microbes"},{"issue":"16","key":"10.1016\/j.intimp.2026.117032_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202417172","article-title":"Natural enzyme-loaded polymeric stealth coating-armed engineered probiotics for metabolism-immuno-enzyme dynamic therapy","volume":"12","author":"Mao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.117032_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aninu.2024.03.016","article-title":"Microencapsulated Lactobacillus plantarum promotes intestinal development through gut colonization of layer chicks","volume":"18","author":"Cui","year":"2024","journal-title":"Anim. Nutr."},{"issue":"21","key":"10.1016\/j.intimp.2026.117032_bb0435","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.3390\/ijms232112852","article-title":"Development and applications of CRISPR\/Cas9-based genome editing in Lactobacillus","volume":"23","author":"Mu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117032_bb0440","doi-asserted-by":"crossref","first-page":"1114588","DOI":"10.3389\/fbioe.2022.1114588","article-title":"CRISPR\/Cas tools for enhancing the biopreservation ability of lactic acid bacteria in aquatic products","volume":"10","author":"Dong","year":"2022","journal-title":"Front Bioeng Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0445","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1038\/s41467-022-35580-z","article-title":"Design of a self-driven probiotic-CRISPR\/Cas9 nanosystem for sono-immunometabolic cancer therapy","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0450","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2026.117032_bb0455","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.3390\/cancers14246033","article-title":"Tumor colonization and therapy by Escherichia coli Nissle 1917 strain in syngeneic tumor-bearing mice is strongly affected by the gut microbiome","volume":"14","author":"Gentschev","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117032_bb0460","article-title":"Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy","volume":"13(1):58","author":"He","year":"2019","journal-title":"J. Biol. Eng."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0465","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4068\/cmj.2016.52.3.173","article-title":"Targeted cancer therapy using engineered Salmonella typhimurium","volume":"52","author":"Zheng","year":"2016","journal-title":"Chonnam Med J."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0470","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3892\/etm.2011.421","article-title":"Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice","volume":"3","author":"Yin","year":"2012","journal-title":"Exp Ther Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0475","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4161\/hv.28549","article-title":"Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation","volume":"10","author":"Mart\u00edn","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"5483","key":"10.1016\/j.intimp.2026.117032_bb0480","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0485","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/mi.2009.116","article-title":"Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis","volume":"3","author":"Vandenbroucke","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"18","key":"10.1016\/j.intimp.2026.117032_bb0490","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1128\/AEM.05153-11","article-title":"Dissimilar properties of two recombinant Lactobacillus acidophilus strains displaying Salmonella FliC with different anchoring motifs","volume":"77","author":"Kajikawa","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0495","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1038\/s41598-025-91180-z","article-title":"Surface display of two neoantigens on Lactiplantibacillus plantarum","volume":"15","author":"Wiull","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117032_bb0500","article-title":"Lactobacillus plantarum surface-displayed ASFV (p14.5) can stimulate immune responses in mice","volume":"10(3):355","author":"Huang","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijfoodmicro.2010.03.037","article-title":"Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice","volume":"144","author":"Watterlot","year":"2010","journal-title":"Int. J. Food Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0510","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s13361-019-02268-6","article-title":"Investigating the proteomic profile of HT-29 colon cancer cells after Lactobacillus kefiri SGL 13 exposure using the SWATH method","volume":"30","author":"Brandi","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0515","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/mi.2010.85","article-title":"Mouse and human intestinal immunity: same ballpark, different players; different rules, same score","volume":"4","author":"Gibbons","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2026.117032_bb0520","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01367-19","article-title":"CRISPR\/Cas9-assisted seamless genome editing in Lactobacillus plantarum and its application in N-acetylglucosamine production","volume":"85","author":"Zhou","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0525","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02669-20","article-title":"Portable CRISPR-Cas9 N system for flexible genome engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei","volume":"87","author":"Goh","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.intimp.2026.117032_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116627","article-title":"Probiotic bacterial adsorption coupled with CRISPR\/Cas12a system for mercury (II) ions detection","volume":"263","author":"Yu","year":"2024","journal-title":"Biosens. Bioelectron."},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0535","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1007\/s00203-021-02404-5","article-title":"LuxS quorum sensing system mediating Lactobacillus plantarum probiotic characteristics","volume":"203","author":"Jiang","year":"2021","journal-title":"Arch. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0540","doi-asserted-by":"crossref","first-page":"9640","DOI":"10.1038\/s41598-020-66531-7","article-title":"Anchoring of heterologous proteins in multiple Lactobacillus species using anchors derived from Lactobacillus plantarum","volume":"10","author":"Mathiesen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117032_bb0545","first-page":"3","article-title":"Clinical application of live biotherapeutic products in infectious diseases","author":"Navalkele","year":"2024","journal-title":"Front Microbiomes"},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.bidere.2025.100039","article-title":"Recent advances of engineered probiotics for therapeutic applications","volume":"7","author":"Zhang","year":"2025","journal-title":"BioDesign Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0555","article-title":"Microbiome bacterial influencers of host immunity and response to immunotherapy","volume":"5","author":"Yousefi","year":"2024","journal-title":"Cell Rep Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0560","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0565","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0570","doi-asserted-by":"crossref","first-page":"2519696","DOI":"10.1080\/19490976.2025.2519696","article-title":"Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens","volume":"17","author":"Carolak","year":"2025","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0575","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17425247.2022.2110582","article-title":"Localized, on-demand, sustained drug delivery from biopolymer-based materials","volume":"19","author":"Wu","year":"2022","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.intimp.2026.117032_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115603","article-title":"Advanced microbiome therapeutics for oral delivery of peptides and proteins: advances, challenges, and opportunities","volume":"222","author":"Gelli","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0585","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70080","article-title":"Engineered bacteria for disease diagnosis and treatment using synthetic biology","volume":"18","author":"Jin","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117032_bb0590","first-page":"8","article-title":"Immunotherapeutic potential of Lactobacillus species as immune checkpoint inhibitors in cancer immunotherapy","author":"R J, Helinto JS, Prena D.","year":"2025","journal-title":"J Bio-X Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0595","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0394632015590948","article-title":"Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates","volume":"28","author":"Fuochi","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"144","key":"10.1016\/j.intimp.2026.117032_bb0600","article-title":"A comprehensive review of the production, beneficial properties, and applications of kefiran, the kefir grain exopolysaccharide","volume":"28","author":"Gentry","year":"2023","journal-title":"International Dairy Journal [Internet]."},{"issue":"4","key":"10.1016\/j.intimp.2026.117032_bb0605","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.idairyj.2008.10.010","article-title":"Effects of kefir supernatant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage","volume":"19","author":"Hong","year":"2009","journal-title":"Int. Dairy J."},{"key":"10.1016\/j.intimp.2026.117032_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.902642","article-title":"Global regulatory frameworks for fermented foods: a review","volume":"9","author":"Mukherjee","year":"2022","journal-title":"Front Nutr."},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0615","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AEM.00024-16","article-title":"Functional analysis of an S-layer-associated fibronectin-binding protein in Lactobacillus acidophilus NCFM","volume":"82","author":"Hymes","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0620","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S0022029913000526","article-title":"Adhesion properties of potentially probiotic Lactobacillus kefiri to gastrointestinal mucus","volume":"81","author":"Carasi","year":"2014","journal-title":"J Dairy Res."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2026.117032_bb0625","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijmm.2012.09.004","article-title":"More than a marine propeller \u2013 the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus","volume":"302","author":"Troge","year":"2012","journal-title":"Int J Med Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0630","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s44320-024-00067-0","article-title":"Bacterial live therapeutics for human diseases","volume":"20","author":"Frutos-Grilo","year":"2024","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.intimp.2026.117032_bb0635","first-page":"0017","volume":"5","author":"Liu","year":"2023","journal-title":"CRISPR-Cas-based engineering of probiotics. BioDesign Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0640","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12934-015-0346-x","article-title":"Cloning strategies for heterologous expression of the bacteriocin enterocin A by Lactobacillus sakei Lb790, Lb. plantarum NC8 and Lb. casei CECT475","volume":"14","author":"Jim\u00e9nez","year":"2015","journal-title":"Microb. Cell Factories"},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0645","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1099\/mic.0.28084-0","article-title":"High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors","volume":"151","author":"S\u00f8rvig","year":"2005","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0650","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1038\/s41598-023-41559-7","article-title":"Lactiplantibacillus plantarum as a novel platform for production and purification of integral membrane proteins using RseP as the benchmark","volume":"13","author":"Kristensen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117032_bb0655","doi-asserted-by":"crossref","first-page":"1286502","DOI":"10.3389\/fbioe.2023.1286502","article-title":"Advances in anti-tumor strategies based on various anaerobic bacteria and their derivatives as drug vehicles","volume":"11","author":"Song","year":"2023","journal-title":"Front Bioeng Biotechnol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0660","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.intimp.2026.117032_bb0665","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/CM9.0000000000003807","article-title":"Engineered bacteria for cancer therapy: advancements, challenges, and future directions","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0670","article-title":"Surface-engineered bacteria in drug development","volume":"17","author":"Leitao","year":"2024","journal-title":"Microb. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0675","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"issue":"530","key":"10.1016\/j.intimp.2026.117032_bb0680","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0685","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41541-024-00869-1","article-title":"High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists","volume":"9","author":"Gilmour","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"17","key":"10.1016\/j.intimp.2026.117032_bb0690","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-10-0735","article-title":"Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts","volume":"70","author":"Kerkar","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0695","doi-asserted-by":"crossref","first-page":"eadc9436","DOI":"10.1126\/sciadv.adc9436","article-title":"Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity","volume":"9","author":"Savage","year":"2023","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0700","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/1040841X.2024.2311653","article-title":"Tumor-targeting bacteria as immune stimulants \u2013 the future of cancer immunotherapy?","volume":"50","author":"Mowday","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2026.117032_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103061","article-title":"Engineering bacteria for cancer immunotherapy","volume":"85","author":"Zalatan","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117032_bb0710","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117032_bb0715","doi-asserted-by":"crossref","first-page":"1226518","DOI":"10.3389\/fimmu.2023.1226518","article-title":"Engineering NK-CAR.19 cells with the IL-15\/IL-15R\u03b1 complex improved proliferation and anti-tumor effect in vivo","volume":"14","author":"Silvestre","year":"2023","journal-title":"Front. Immunol."},{"issue":"100","key":"10.1016\/j.intimp.2026.117032_bb0720","doi-asserted-by":"crossref","first-page":"eadn9879","DOI":"10.1126\/sciimmunol.adn9879","article-title":"Programmable bacteria synergize with PD-1 blockade to overcome cancer cell\u2013intrinsic immune resistance mechanisms","volume":"9","author":"Li","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0725","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","article-title":"Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention","volume":"2","author":"Ho","year":"2018","journal-title":"Nat Biomed Eng."},{"issue":"7614","key":"10.1016\/j.intimp.2026.117032_bb0730","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2026.117032_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10660","article-title":"Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme","volume":"8","author":"El-Sayed","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0740","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/toxins14020078","article-title":"(ClyA): a bacterial virulence factor with potential applications in nanopore technology, vaccine development, and tumor therapy","volume":"14","author":"Murase","year":"2022","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0745","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12915-024-02086-7","article-title":"LADS: a powerful vaccine platform for cancer immunotherapy and prevention","volume":"22","author":"Sun","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2026.117032_bb0750","first-page":"133","article-title":"Listeria monocytogenes and the inflammasome: from cytosolic bacteriolysis to tumor immunotherapy","volume":"397","author":"Theisen","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0755","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/nu11051026","article-title":"Effects of intestinal microbial\u2013elaborated butyrate on oncogenic signaling pathways","volume":"11","author":"Chen","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0760","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.3390\/ijms24065069","article-title":"Modulation of the tumor microenvironment by microbiota-derived short-chain fatty acids: impact in colorectal cancer therapy","volume":"24","author":"Gomes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0765","doi-asserted-by":"crossref","first-page":"1788899","DOI":"10.1080\/19490976.2020.1788899","article-title":"Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity","volume":"12","author":"Dong","year":"2020","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0770","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s44319-025-00386-9","article-title":"Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite","volume":"26","author":"Vaaben","year":"2025","journal-title":"EMBO Rep."},{"issue":"7662","key":"10.1016\/j.intimp.2026.117032_bb0775","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0780","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1038\/s41467-025-66622-x","article-title":"Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays","volume":"16","author":"Yue","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0785","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","article-title":"Lactobacillus rhamnosus GG induces cGAS\/STING-dependent type I interferon and improves response to immune checkpoint blockade","volume":"71","author":"Si","year":"2021","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410011","article-title":"Nano-armed LimosiLactobacillus reuteri for enhanced photo-immunotherapy and microbiota tryptophan metabolism against colorectal cancer","volume":"12","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.117032_bb0795","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1535-7163.MCT-25-0404","article-title":"Inhibiting arginine metabolism via ALDH2\/ARG2 axis blockade potentiates immune checkpoint inhibitors in colorectal cancer","volume":"24","author":"Cai","year":"2025","journal-title":"Mol. Cancer Ther."},{"issue":"14","key":"10.1016\/j.intimp.2026.117032_bb0800","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117032_bb0805","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fphar.2020.00554","article-title":"Like cures like: pharmacological activity of anti-inflammatory lipopolysaccharides from gut microbiome","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-023-00429-w","article-title":"Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment","volume":"9","author":"Sulit","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0815","doi-asserted-by":"crossref","first-page":"bpac024","DOI":"10.1093\/biomethods\/bpac024","article-title":"A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis","volume":"7","author":"Greenlee","year":"2022","journal-title":"Biol Methods Protoc."},{"issue":"11","key":"10.1016\/j.intimp.2026.117032_bb0820","first-page":"755","article-title":"Colorectal cancer therapy using a Pediococcus pentosaceus SL4 drug delivery system secreting lactic acid bacteria-derived protein p8","volume":"42","author":"An","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2026.117032_bb0825","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0830","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41401-022-00953-z","article-title":"Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights","volume":"44","author":"Ni","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0835","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2026.117032_bb0840","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1073\/pnas.0500098102","article-title":"Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization","volume":"102","author":"Mohamadzadeh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.intimp.2026.117032_bb0845","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2507711122","article-title":"Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment","volume":"122","author":"Yuan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.117032_bb0850","article-title":"Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy","author":"Yang","year":"2024","journal-title":"Res Sq."},{"key":"10.1016\/j.intimp.2026.117032_bb0855","doi-asserted-by":"crossref","first-page":"1017780","DOI":"10.3389\/fimmu.2022.1017780","article-title":"Attenuated Salmonella potentiate PD-L1 blockade immunotherapy in a preclinical model of colorectal cancer","volume":"13","author":"Al-Saafeen","year":"2022","journal-title":"Front. Immunol."},{"issue":"803","key":"10.1016\/j.intimp.2026.117032_bb0860","doi-asserted-by":"crossref","first-page":"eado8395","DOI":"10.1126\/scitranslmed.ado8395","article-title":"Synthetic biology\u2013driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer","volume":"17","author":"Mi","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"6161","key":"10.1016\/j.intimp.2026.117032_bb0865","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0870","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/bbb\/zbaa057","article-title":"Potentiated antitumor effects of APS001F\/5-FC combined with anti-PD-1 antibody in a CT26 syngeneic mouse model","volume":"85","author":"Shioya","year":"2021","journal-title":"Bioscience Biotechnology and Biochemistry [Internet]."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0875","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/biomedicines10051128","article-title":"Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells","volume":"10","author":"Dikeocha","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb0880","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003725","article-title":"Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite","volume":"10","author":"Renga","year":"2022","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.intimp.2026.117032_bb0885","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fcimb.2017.00279","article-title":"A genetically modified attenuated Listeria vaccine expressing HPV16 E7 kill tumor cells in direct and antigen-specific manner","volume":"7","author":"Jia","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117032_bb0890","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642316","article-title":"Clinical experience and recent advances in the development of Listeria-based tumor immunotherapies","volume":"12","author":"Oladejo","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0895","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.bjc.6601211","article-title":"Mechanism of cell death induced by the novel enzyme-prodrug combination nitroreductase\/CB1954 and identification of synergism with 5-fluorouracil","volume":"89","author":"Palmer","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"34","key":"10.1016\/j.intimp.2026.117032_bb0900","doi-asserted-by":"crossref","first-page":"23497","DOI":"10.1021\/acsnano.4c07115","article-title":"Oral Saccharomyces cerevisiae-guided enzyme prodrug therapy combined with immunotherapy for treatment of orthotopic colorectal cancer","volume":"18","author":"Qin","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117032_bb0905","article-title":"Modulation of gut microbiota to enhance effect of checkpoint inhibitor immunotherapy","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117032_bb0910","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3389\/fmicb.2018.01588","article-title":"Toll-like receptor 2-mediated suppression of colorectal cancer pathogenesis by polysaccharide A from Bacteroides fragilis","volume":"9","author":"Sittipo","year":"2018","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117032_bb0915","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4161\/hv.23871","article-title":"Listeriolysin O as a strong immunogenic molecule for development of new anti-tumor vaccines","volume":"9","author":"Sun","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8038","key":"10.1016\/j.intimp.2026.117032_bb0920","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117032_bb0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anaerobe.2013.05.005","article-title":"A clinical and epidemiological review of non-toxigenic Clostridium difficile","volume":"22","author":"Natarajan","year":"2013","journal-title":"Anaerobe"},{"key":"10.1016\/j.intimp.2026.117032_bb0930","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.804949","article-title":"Host immune responses to Clostridioides difficile: toxins and beyond","volume":"12","author":"Nibbering","year":"2021","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117032_bb0935","doi-asserted-by":"crossref","first-page":"eade5079","DOI":"10.1126\/sciadv.ade5079","article-title":"Versatility of bacterial outer membrane vesicles in regulating intestinal homeostasis","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0940","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nbt840","article-title":"Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10","volume":"21","author":"Steidler","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117032_bb0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.009","article-title":"Advances in bacterial cancer therapies using synthetic biology","volume":"5","author":"Chien","year":"2017","journal-title":"Curr Opin Syst Biol."},{"key":"10.1016\/j.intimp.2026.117032_bb0950","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fmicb.2015.00433","article-title":"Commentary: Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis","volume":"6","author":"Tyagi","year":"2015","journal-title":"Front Microbiol."},{"issue":"3 Suppl","key":"10.1016\/j.intimp.2026.117032_bb0955","first-page":"1261","article-title":"Persistence and safety assessment of novel probiotic strain Lactobacillus plantarum 1 strain Lp86 and Lp36 in Salmonella typhi infected mice","volume":"32","author":"Baloch","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117032_bb0960","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s15010-015-0798-2","article-title":"Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature","volume":"43","author":"Meini","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.intimp.2026.117032_bb0965","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fmed.2020.00237","article-title":"Live biotherapeutic products, a road map for safety assessment","volume":"7","author":"Rouanet","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.intimp.2026.117032_bb0970","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jgh.16164","article-title":"Lactobacillus rhamnosus GG alleviates colitis caused by chemotherapy via biofilm formation","volume":"38","author":"Qiu","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117032_bb0975","article-title":"Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information [Internet]. Silver Spring (MD): U.S","author":"Office of the Commissioner","year":"2018","journal-title":"Food and Drug Administration"},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0980","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1471-0307.2006.00255.x","article-title":"Genetically modified Lactococcus lactis: novel tools for drug delivery","volume":"59","author":"Steidler","year":"2006","journal-title":"Int. J. Dairy Technol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb0985","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4161\/hv.26954","article-title":"Two-tiered biological containment strategy for Lactococcus lactis-based vaccine or immunotherapy vectors","volume":"10","author":"Hanin","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb0990","article-title":"Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case report","volume":"4","author":"Rubin","year":"2022","journal-title":"Infect Prev Pract."},{"issue":"Suppl. 6","key":"10.1016\/j.intimp.2026.117032_bb0995","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1093\/cid\/ciad642","article-title":"Review article: safety of live biotherapeutic products used for the prevention of Clostridioides difficile infection recurrence","volume":"77","author":"Gonzales-Luna","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.117032_bb1000","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s12276-020-0386-0","article-title":"Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches","volume":"52","author":"Min","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117032_bb1005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s44321-025-00198-3","article-title":"Model systems to study tumor-microbiome interactions in early-onset colorectal cancer","volume":"17","author":"Richter","year":"2025","journal-title":"EMBO Mol Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117032_bb1010","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1038\/s41596-021-00562-w","article-title":"Coculture of primary human colon monolayer with human gut bacteria","volume":"16","author":"Zhang","year":"2021","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb1015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijfoodmicro.2008.11.012","article-title":"Microencapsulation of Lactobacillus plantarum spp in an alginate matrix coated with whey proteins","volume":"129","author":"Gbassi","year":"2009","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.intimp.2026.117032_bb1020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.msec.2017.04.010","article-title":"Encapsulation of Lactobacillus kefiri in alginate microbeads using a double novel aerosol technique","volume":"77","author":"Demitri","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.intimp.2026.117032_bb1025","article-title":"Microencapsulation in alginate-pectin based capsules of probiotic Lactobacillus plantarum WCFS1: pectin source and degree of blockwise distribution of methyl esters are critical parameters for the efficacy of protection under gastrointestinal conditions","volume":"170","author":"Tang","year":"2025","journal-title":"Food Hydrocoll."},{"issue":"1","key":"10.1016\/j.intimp.2026.117032_bb1030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/fsn3.2662","article-title":"Evaluation of tolerance to artificial gastroenteric juice and fermentation characteristics of Lactobacillus strains isolated from human","volume":"10","author":"Liu","year":"2022","journal-title":"Food Sci Nutr."},{"issue":"15","key":"10.1016\/j.intimp.2026.117032_bb1035","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1128\/AEM.00078-08","article-title":"Variations in the degree of d-alanylation of teichoic acids in Lactococcus lactis alter resistance to cationic antimicrobials but have no effect on bacterial surface hydrophobicity and charge","volume":"74","author":"Giaouris","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"issue":"24","key":"10.1016\/j.intimp.2026.117032_bb1040","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/cancers16244271","article-title":"Insights into the relationship between the gut microbiome and immune checkpoint inhibitors in solid tumors","volume":"16","author":"Ciernikova","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117032_bb1045","series-title":"Probiotics in colorectal cancer patients (NCT00936572) [Internet]","author":"ClinicalTrials.gov","year":"2026"},{"key":"10.1016\/j.intimp.2026.117032_bb1050","author":"CareAcross"},{"key":"10.1016\/j.intimp.2026.117032_bb1055","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.intimp.2026.117032_bb1060","series-title":"Dietary fiber and probiotics in advanced colorectal cancer (NCT07194954) [Internet]","author":"ClinicalTrials.gov","year":"2026"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:41:27Z","timestamp":1784230887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":212,"alternative-id":["S1567576926008787"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117032","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From fermentation to pharmabiotics: engineering kefir-derived Lactobacillus for targeted intratumoral immunotherapy in colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117032"}}